News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
448,023 Results
Type
Article (22850)
Company Profile (167)
Press Release (425006)
Section
Business (143253)
Career Advice (1302)
Deals (25662)
Drug Delivery (99)
Drug Development (54034)
Employer Resources (90)
FDA (9872)
Job Trends (10969)
News (238963)
Policy (22952)
Tag
Academia (1350)
Alliances (38414)
Alzheimer's disease (741)
Approvals (9854)
Artificial intelligence (133)
Bankruptcy (229)
Best Places to Work (8410)
Breast cancer (119)
Cancer (969)
Cardiovascular disease (90)
Career advice (1066)
Cell therapy (157)
Clinical research (44527)
Collaboration (421)
Compensation (208)
COVID-19 (1469)
C-suite (102)
Data (934)
Diabetes (126)
Diagnostics (3975)
Drug pricing (106)
Earnings (51874)
Employer resources (82)
Events (62816)
Executive appointments (386)
FDA (10383)
Funding (309)
Gene therapy (126)
GLP-1 (556)
Government (3195)
Healthcare (11950)
Infectious disease (1545)
Inflammatory bowel disease (80)
Interviews (193)
IPO (10525)
Job creations (2854)
Job search strategy (938)
Layoffs (295)
Legal (5244)
Lung cancer (139)
Manufacturing (184)
Medical device (6124)
Medtech (6127)
Mergers & acquisitions (15343)
Metabolic disorders (409)
Neuroscience (985)
NextGen: Class of 2025 (4482)
Non-profit (2788)
Northern California (1060)
Obesity (255)
Opinion (194)
Patents (95)
People (43497)
Pharmaceutical (82)
Phase I (13829)
Phase II (19009)
Phase III (15090)
Pipeline (471)
Policy (89)
Postmarket research (1732)
Preclinical (4948)
Radiopharmaceuticals (179)
Rare diseases (197)
Real estate (4712)
Regulatory (15650)
Research institute (1261)
Resumes & cover letters (207)
Southern California (979)
Startups (2430)
United States (10245)
Vaccines (262)
Weight loss (213)
Date
Today (123)
Last 7 days (301)
Last 30 days (1290)
Last 365 days (22553)
2025 (1212)
2024 (22810)
2023 (25786)
2022 (34443)
2021 (36716)
2020 (36532)
2019 (32855)
2018 (25150)
2017 (22468)
2016 (21443)
2015 (24716)
2014 (19159)
2013 (16203)
2012 (17502)
2011 (18139)
2010 (16560)
Location
Africa (528)
Arizona (93)
Asia (29252)
Australia (3847)
California (2454)
Canada (1212)
China (261)
Colorado (130)
Connecticut (130)
Europe (62428)
Florida (380)
Illinois (310)
Indiana (181)
Japan (82)
Maryland (478)
Massachusetts (1942)
Michigan (92)
Minnesota (158)
New Jersey (900)
New York (675)
North Carolina (582)
Northern California (1060)
Ohio (118)
Pennsylvania (613)
South America (789)
Southern California (979)
Texas (374)
Washington State (220)
448,023 Results for "pci pharma services lsne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
September 24, 2024
·
5 min read
Pharm Country
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics has chosen PCI Pharma Services, a world-leading global contract development and manufacturing organization to formulate, package, and distribute ALD-102, an siRNA-based investigational injectable treatment for inflammatory dermatological conditions, all under one roof at PCI’s San Diego facility.
October 19, 2023
·
4 min read
Deals
PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the closing of the previously announced acquisition of Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization headquartered in Bedford, New Hampshire.
December 14, 2021
·
2 min read
Deals
PCI Pharma Services Announces the Acquisition of LSNE to Add End-To-End Global Sterile Fill-Finish and Lyophilization Manufacturing Capabilities
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global integrated solutions provider, announced it has signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire, from global private equity firm Permira.
October 12, 2021
·
3 min read
Pharm Country
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services, a leading global contract development and manufacturing organization, announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational.
April 18, 2023
·
4 min read
Pharm Country
Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment
PCI Pharma Services, a leading global contract development and manufacturing organization, announced the addition of three new exceptional automated sterile fill-finish machines in its San Diego and Melbourne facilities.
February 2, 2022
·
4 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
SUPIRA MEDICAL INITIATES U.S. EARLY FEASIBILITY STUDY (EFS) FOR HIGH-RISK PCI
November 21, 2024
·
2 min read
Press Releases
Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
October 29, 2024
·
4 min read
Press Releases
PCI Biotech first half 2024 interim results
August 28, 2024
·
3 min read
1 of 44,803
Next
